Home » Topics » Regulatory » Patents

Patents
RSS

Novel series of inhibitors of protein farnesyltransferase developed at RPR

Oct. 14, 1998

Erythromycin derivatives for Gram-positive infections disclosed by Hoechst Marion Roussel

Oct. 13, 1998

Lundbeck develops new antipsychotic agents acting on D1 receptors

Oct. 13, 1998

Novel central 5-HT1A receptor agonists characterized in binding and animal studies

Oct. 13, 1998

Antiatherosclerotic compounds prepared by Bayer scientists

Oct. 13, 1998

Nicotinic acetylcholine receptor ligands from Pfizer for addictive and CNS disorders

Oct. 13, 1998

Ono's new PGE2 derivatives show binding affinity for EP2 receptors

Oct. 13, 1998

European academic researchers disclose nonxanthine adenosine receptor antagonists

Oct. 9, 1998

New moenomycin salts for H. pylori-related disorders

Oct. 9, 1998

HMR presents new bile acid uptake inhibitors for hyperlipidemic disorders

Oct. 9, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
ASH 2025: Ianalumab data offer break from chronic ITP therapy
BioWorld
Novartis AG’s monoclonal antibody, ianalumab (VAY-736), when added to standard-of-care eltrombopag, extended disease control of primary immune thrombocytopenia...